RCAG
CDNA icon

Rehmann Capital Advisory Group’s CareDx CDNA Stock Holding History

Rehmann Capital Advisory Group’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,555
Closed -$236K – 1729
2019
Q2 		$236K Sell
6,555
-1,164
-15% -$37.3K 0.03% 402
2019
Q1 		$243K Buy
+7,719
New +$225K 0.03% 368

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Rehmann Capital Advisory Group's CDNA Position: Q3 2019 in Review

Rehmann Capital Advisory Group sold out of CareDx (CDNA) in Q3 2019, closing a stake of 6,555 shares — an estimated $236K sold.

Rehmann Capital Advisory Group first reported a position in CDNA in Q1 2019 and held it in 2 quarters. The position peaked at $243K in Q1 2019. 174 funds tracked by Wall St. Rank hold CDNA as of Q3 2019.

  • Rehmann Capital Advisory Group reported no remaining CareDx position as of Q3 2019 after selling out during the quarter.
  • Rehmann Capital Advisory Group sold 6,555 CareDx shares in Q3 2019, an estimated $236K.
  • Rehmann Capital Advisory Group first reported a position in CareDx in Q1 2019 and held it in 2 quarters.
  • Rehmann Capital Advisory Group's CareDx position peaked at $243K in Q1 2019.
  • 174 funds tracked by Wall St. Rank held CareDx as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.